{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:16:28Z","timestamp":1740122188408,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100013228","name":"Faroese Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013228","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Torben & Alice Frimodts Foundation"},{"name":"Aage & Johanne Louis-Hansens Foundation"},{"name":"Faroese Foundation"},{"name":"Betri Foundation"},{"name":"EU Horizon Europe program grant miGut-Health: personalised blueprint of intestinal health","award":["101095470"],"award-info":[{"award-number":["101095470"]}]},{"DOI":"10.13039\/501100001734","name":"Copenhagen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10620-024-08721-1","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T17:55:55Z","timestamp":1731606955000},"page":"4446-4457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparing Environmental Risk Factors at Diagnosis in Faroese and Danish Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"69","author":[{"given":"K\u00e1ri Rubek","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederikke Agerbo","family":"Modin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3nger\u00f0","family":"Midjord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Vang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjun \u00e1 Fr\u00ed\u00f0riksm\u00f8rk","family":"Berbis\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herborg L\u00edggjasard\u00f3ttir","family":"Johannesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Frederik","family":"Dahlerup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibeke","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebbe","family":"Langholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Munkholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turid","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Burisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"8721_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S2468-1253(23)00003-1","volume":"8","author":"J Burisch","year":"2023","unstructured":"Burisch J, Zhao M, Odes S et al. The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2023;8:458\u2013492.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"8721_CR2","doi-asserted-by":"publisher","first-page":"e065186","DOI":"10.1136\/bmjopen-2022-065186","volume":"13","author":"R Wang","year":"2023","unstructured":"Wang R, Li Z, Liu S et al. Global, regional, and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open. 2023;13:e065186.","journal-title":"BMJ Open."},{"key":"8721_CR3","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2018","unstructured":"Ng SC, Shi HY, Hamidi N et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390:2769\u20132778.","journal-title":"Lancet."},{"key":"8721_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/ecco-jcc\/jjad155","volume":"18","author":"KR Nielsen","year":"2024","unstructured":"Nielsen KR, Midjord J, Lophaven SN et al. The incidence and prevalence of inflammatory bowel disease continues to increase in the Faroe Islands\u2014a cohort study from 1960\u20132020. J Crohns Colitis. 2024;18:308\u2013319.","journal-title":"J Crohns Colitis."},{"key":"8721_CR5","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/apt.13975","volume":"45","author":"T Hammer","year":"2017","unstructured":"Hammer T, Lophaven SN, Nielsen KR et al. Inflammatory bowel diseases in Faroese-born Danish residents and their offspring: further evidence of the dominant role of environmental factors in IBD development. Aliment Pharmacol Ther. 2017;45:1107\u20131114.","journal-title":"Aliment Pharmacol Ther."},{"key":"8721_CR6","first-page":"287","volume":"44","author":"P Munkholm","year":"1997","unstructured":"Munkholm P. Crohn\u2019s disease-occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull. 1997;44:287\u2013302.","journal-title":"Dan Med Bull."},{"key":"8721_CR7","first-page":"400","volume":"46","author":"E Langholz","year":"1999","unstructured":"Langholz E. Ulcerative colitis. An epidemiological study based on a regional inception cohort, with special reference to disease course and prognosis. Dan Med Bull. 1999;46:400\u2013415.","journal-title":"Dan Med Bull."},{"key":"8721_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/gutjnl-2013-304636","volume":"63","author":"J Burisch","year":"2014","unstructured":"Burisch J, Pedersen N, Cukovic-Cavka S et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut. 2014;63:588\u2013597.","journal-title":"Gut."},{"key":"8721_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/apm.13334","volume":"131","author":"J Burisch","year":"2023","unstructured":"Burisch J. Long-term disease course, cost and prognosis of inflammatory bowel disease: epidemiological studies of a European and a Danish inception cohort. APMIS. 2023;131:1\u201346.","journal-title":"APMIS."},{"key":"8721_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.crohns.2013.11.021","volume":"8","author":"J Burisch","year":"2014","unstructured":"Burisch J, Pedersen N, Cukovic-Cavka S et al. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe\u2014an ECCO-EpiCom study. J Crohns Colitis. 2014;8:607\u2013616.","journal-title":"J Crohns Colitis."},{"key":"8721_CR11","doi-asserted-by":"publisher","first-page":"5A","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A\u201336A.","journal-title":"Can J Gastroenterol."},{"key":"8721_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.crohns.2008.01.004","volume":"2","author":"I Vind","year":"2008","unstructured":"Vind I, Riis L, Jespersgaard C et al. Genetic and environmental factors as predictors of disease severity and extent at time of diagnosis in an inception cohort of inflammatory bowel disease, Copenhagen County and City 2003\u20132005. J Crohns Colitis. 2008;2:162\u2013169.","journal-title":"J Crohns Colitis."},{"key":"8721_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/01.mib.0000228998.29466.ac","volume":"12","author":"J Halfvarson","year":"2006","unstructured":"Halfvarson J, Jess T, Magnuson A et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis. 2006;12:925\u2013933.","journal-title":"Inflamm Bowel Dis."},{"key":"8721_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.crohns.2012.05.024","volume":"7","author":"C Jakobsen","year":"2013","unstructured":"Jakobsen C, Paerregaard S, Munkholm P et al. Environmental factors and risk of developing paediatric inflammatory bowel disease\u2014a population based study 2007\u20132009. J Crohns Colitis. 2013;7:79\u201388.","journal-title":"J Crohns Colitis."},{"key":"8721_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/sj.ejhg.5201578","volume":"14","author":"TD Als","year":"2006","unstructured":"Als TD, Jorgensen TH, B\u00f8rglum AD et al. Highly discrepant proportions of female and male Scandinavian and British Isles ancestry within the isolated population of the Faroe Islands. Eur J Hum Genet. 2006;14:497\u2013504.","journal-title":"Eur J Hum Genet."},{"key":"8721_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00439-004-1117-7","volume":"115","author":"TH Jorgensen","year":"2004","unstructured":"Jorgensen TH, Buttensch\u00f6n HN, Wang AG et al. The origin of the isolated population of the Faroe Islands investigated using Y chromosomal markers. Hum Genet. 2004;115:19\u201328.","journal-title":"Hum Genet."},{"key":"8721_CR17","unstructured":"Visit Faroe Islands. The food culture of the Faroe Islands. Available at: https:\/\/visitfaroeislands.com\/en\/about1\/guest-articles1\/the-food-culture-of-the-faroe-islands. Accessed October 22, 2024."},{"key":"8721_CR18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1093\/ecco-jcc\/jjw050","volume":"10","author":"T Hammer","year":"2016","unstructured":"Hammer T, Nielsen KR, Munkholm P et al. The Faroese IBD study: Incidence of inflammatory bowel diseases across 54 years of population-based data. J Crohns Colitis. 2016;10:934\u2013942.","journal-title":"J Crohns Colitis."},{"key":"8721_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/gutjnl-2016-312673","volume":"66","author":"S Subramanian","year":"2017","unstructured":"Subramanian S, Ekbom A, Rhodes JM. Recent advances in clinical practice: a systemic review of isolated colonic Crohn\u2019s disease: the third IBD? Gut. 2017;66:362\u2013381.","journal-title":"Gut."},{"key":"8721_CR20","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1111\/j.1572-0241.2008.02064.x","volume":"103","author":"JA Cornish","year":"2008","unstructured":"Cornish JA, Tan E, Simillis K et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008;103:2394\u20132400.","journal-title":"Am J Gastroenterol."},{"key":"8721_CR21","unstructured":"Nordic Welfare Centre. Smoking\u2014one of the biggest threats to public health in the Nordic region. Available at: https:\/\/nordicwelfare.org\/en\/nyheter\/smoking-one-of-the-biggest-threats-to-public-health-in-the-nordic-region\/. Accessed June 13, 2024."},{"key":"8721_CR22","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/ecco-jcc\/jjx002.038","volume":"11","author":"C Maaser","year":"2017","unstructured":"Maaser C, Langholz E, Gordon H et al. European Crohn\u2019s and Colitis Organisation topical review on environmental factors in IBD. J Crohns Colitis. 2017;11:905\u2013920.","journal-title":"J Crohns Colitis."},{"key":"8721_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/jama.2011.2034","volume":"307","author":"P Grandjean","year":"2012","unstructured":"Grandjean P, Andersen EW, Budtz-J\u00f8rgensen E et al. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA. 2012;307:391\u2013397.","journal-title":"JAMA."},{"key":"8721_CR24","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1136\/gutjnl-2024-331914","volume":"73","author":"TE Adolph","year":"2024","unstructured":"Adolph TE, Meyer M, Jukic A et al. Heavy arch: from inflammatory bowel diseases to metabolic disorders. Gut. 2024;73:1376-1387. https:\/\/doi.org\/10.1136\/gutjnl-2024-331914","journal-title":"Gut."},{"key":"8721_CR25","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1177\/2050640619852244","volume":"7","author":"T Hammer","year":"2019","unstructured":"Hammer T, Lophaven SN, Nielsen KR et al. Dietary risk factors for inflammatory bowel diseases in a high-risk population: Results from the Faroese IBD study. United European Gastroenterol J. 2019;7:924\u2013932.","journal-title":"United European Gastroenterol J."},{"key":"8721_CR26","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/ibd\/izab355","volume":"28","author":"MF Berbis\u00e1","year":"2022","unstructured":"Berbis\u00e1 MF, Nielsen KR, Ingham AC et al. Similar gut bacterial composition between patients with ulcerative colitis and healthy controls in a high incidence population: a cross-sectional study of the Faroe Islands IBD cohort. Inflamm Bowel Dis. 2022;28:1081\u20131089.","journal-title":"Inflamm Bowel Dis."},{"key":"8721_CR27","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1016\/j.cgh.2023.01.012","volume":"21","author":"N Narula","year":"2023","unstructured":"Narula N, Chang NH, Mohammad D et al. Food processing and risk of inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21:2483\u20132495.e1.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"8721_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1554","volume":"14","author":"N Narula","year":"2021","unstructured":"Narula N, Wong ECL, Dehghan M et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ. 2021;14:n1554.","journal-title":"BMJ."},{"key":"8721_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/nu13010216","volume":"13","author":"AE Ratajczak","year":"2021","unstructured":"Ratajczak AE, Szymczak-Tomcsak A, Zawada A et al. Does drinking coffee and tea affect bone metabolism in patients with inflammatory bowel diseases? Nutrients. 2021;13:216.","journal-title":"Nutrients."},{"key":"8721_CR30","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/ecco-jcc\/jjae053","volume":"18","author":"HT Tiong","year":"2024","unstructured":"Tiong HT, Fan D, Frampton C et al. Physical activity is associated with a decreased risk of developing inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2024;18:1476-1485.","journal-title":"J Crohns Colitis."},{"key":"8721_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/nep.13706","volume":"25","author":"KJ Jager","year":"2020","unstructured":"Jager KJ, Tripepi G, Chesnaye NC et al. Where to look for the most frequent bias? Nephrology (Carlton). 2020;25:435\u2013441.","journal-title":"Nephrology (Carlton)."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08721-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08721-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08721-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T17:13:01Z","timestamp":1732727581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08721-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["8721"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08721-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JB reports grants and personal fees from AbbVie, Janssen-Cilag, MSD, Takeda, Tillots Pharma, and Bristol Myers Squibb. JB also reports personal fees from Celgene, Pfizer, Samsung Bioepis, Pharmacosmos, Ferring, and Galapagos and grants from Novo Nordisk, unrelated to the submitted work. EL reports speaker\u2019s fees from Ferring Pharmaceuticals, Takeda, Janssen-Cilag, Tillotts, and MSD. EL also reports having served as an advisory board member for Ferring Pharmaceuticals and Takeda. VA reports personal fees from MSD (Merck) unrelated to the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}